Navigation Links
Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
Date:8/5/2008

WHIPPANY, N.J., Aug. 5 /PRNewswire/ -- Nexgen Spine, a leading developer of innovative spinal implants for the surgical treatment of degenerative disc disease, announced today that it has received CE mark approval to market the Physio-L(R) Lumbar Artificial Disc in the European Union.

"We are delighted that the Physio-L(R) Artificial Disc Prosthesis has received CE mark approval," said Alastair Clemow, Ph.D., President and CEO of Nexgen Spine. "This represents an important milestone in our plan to launch a full range of artificial disc prostheses based on our proprietary elastomeric disc technology." Dr. Clemow further added, "the fact that the Physio-L(R) is the first of the next generation elastomeric lumbar discs to receive a CE mark makes this approval even more exciting."

The Physio-L(R) Artificial Disc is an elastomeric disc prosthesis designed to be used in the lumbar spine for patients suffering from degenerative disc disease. The device's proprietary elastomeric technology enables the disc to closely mimic the mechanical properties of the natural disc and represents a significant advance over current designs of disc prostheses.

"The unique properties of the Physio-L(R) help restore the natural shock absorption of the disc," said Casey Lee MD, Chairman and Founder of Nexgen Spine. "This allows the surgeon to restore function to the patient's disc. The clinical data for the Physio-L(R) are demonstrating outstanding improvements in both patient disability and pain, supporting the concept of using elastomeric polymers for total disc prostheses."

Nexgen Spine, Inc. is dedicated to providing its customers with high quality products that promote pain relief, preservation of motion and restoration of function by applying state-of-the-art design, biomaterials, and manufacturing technology. The company, based in Whippany NJ, is ISO 13485:2003 certified.

Contact: Alastair Clemow, President & CEO at 973-386-1800 ext 302 (aclemo
'/>"/>

SOURCE Nexgen Spine
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
2. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
3. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
4. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
5. SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
6. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
9. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
10. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
11. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswi...daq: ALXA ) announced today that its corporate pr...nual Piper Jaffray Health Care Conference on Wedne... The presentation will be webcast from The New Yor...y Thomas B. King, Alexza President and CEO. ,...
(Date:11/19/2009)..., , ABBOTT PARK, Ill., Nov. 19 /PRNewswire-...bott (NYSE: ABT ) as one of its Most Admired Cor... The Deal honored Abbott as its Most Admired De...trategic use of acquisitions and divestitures sinc... has reshaped its business portfolio with a focus ...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 As ...unning noses is here. Here,s more on preparing you...il-Janssen Pharmaceuticals Inc. at: ,, http:...nRfCsbxc9R2VXAOIF ,, Medialink is a division...cess video, audio, text, graphics and photos at ...
Breaking Medicine Technology:Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Regado Biosciences Expands Medical Advisory Board 13085 1Regado Biosciences Expands Medical Advisory Board 13085 2Regado Biosciences Expands Medical Advisory Board 13085 3Regado Biosciences Expands Medical Advisory Board 13085 4Cytokine PharmaSciences Initiates Phase I Study of Oral Anti Inflammatory Agent CPSI 2364 4746 1Cytokine PharmaSciences Initiates Phase I Study of Oral Anti Inflammatory Agent CPSI 2364 4746 2Elder Boom Will Be Felt Worldwide 52094 1Elder Boom Will Be Felt Worldwide 52094 2
...007 /PRNewswire-FirstCall/ --,Telik, Inc. announce...Phase 2 trial of the triplet combination of TELCYT...aclitaxel will be,presented at the 98th annual mee...ch (AACR) in Los Angeles. Preclinical studies of,c...ncer cell growth,inhibition with TELCYTA in combin...
...pril 11, 2007,/PRNewswire-FirstCall/ -- Rigel Phar... on R788, which is currently in ongoing,Phase 2 cl...ITP),rheumatoid arthritis (RA) and lymphoma patie...at blocks the activation of mast cells,macrophage...responses and tissue damage. , Rigel commenced an ...
Other Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 2Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 3Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 4
(Date:11/21/2009)...Nov. 21 Tonight, in a p...Senator Reid,s version of the government takeover ...ems included in this bill; like the public option,...nt funding for elective abortion, which is the mos...the bill provides subsidies for private plans that...
(Date:11/21/2009)...ll provides for an unprecedented expansion of fede...f it is not for preserving and protecting human li...d." Charmaine Yoest ,, WASHINGTON, Nov. 21 /...e Action President and CEO Dr. Charmaine Yoest res...g the following statement: ,, "This was a pro-...
(Date:11/21/2009)... Nov. 21 A regional ini...rciasis (river blindness) in the Americas has subs... recent years, as evidenced by a 31% decrease in t...istration in six endemic countries. Results were ...merican Society of Tropical Medicine and Hygiene (...
(Date:11/21/2009)...vember 21, 2009 Test Tes...t Test Test Test Test Test Test Test,Test Test Tes...t Test Test,Test Test Test Test Test Test Test Tes...st More test More test More test More test More te...st More test More test More,test More test , , ...
(Date:11/21/2009)... Innovative medical apparel company launches men,... San Clemente, Calif. (PRWEB) Novemb...h medical apparel, today announced the launch of i... 2009, a leading international trade fair for the ...lita inaugurates its men,s collection with three v...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3
...en as people struggle to cope with economic uncert...,s still possible to live a joyful, vital "best" l...y years, Harvard trained psychiatrist Dr. Richar...how to find the "best" in our living, the despair ...
... John K. Davis, II has been named Senior Vice Pre...an Board of Internal Medicine (ABIM), effective Ap...will work closely with senior management and the B...gy initiatives that support ABIM,s mission to ensu...
...e Mashour and David Glick highlight the serious is...view published by F1000 Medicine Reports. , Consc...y distressing condition leading to post-operative ...esthesia and Pain Management, writes that intra-op...
... 2 Helen of Troy Limited (Nasdaq: HELE ), desig...e personal care and household consumer products, t...reviously reported agreement to acquire the global... a trusted reputation with stylists and consumers ...
... 2 Spring is in the air, and along with it, tree,...y sufferer,s immune system a curve ball. But the A...Balanced Living magazine uncovers five other su... allergens as foreign bodies and launches an infla...
... InVitria,s Recombinant Albumin-DX eliminates s...d enhances diagnostic performance by improving spe... CO (PRWEB) April 2, 2009 -- Addressing significan... albumin products. InVitria,s Recombinant Albumin-...
Other Medicine News:Health News:Psychiatrist Dr. Richard Esser: How to Find the Best of Life in the Worst of Times 2Health News:John K. Davis, II to Join the American Board of Internal Medicine as Chief Information Officer 2Health News:Helen of Troy Limited Announces Closing of Global Infusium Brand Acquisition From Procter & Gamble 2Health News:Helen of Troy Limited Announces Closing of Global Infusium Brand Acquisition From Procter & Gamble 3Health News:Helen of Troy Limited Announces Closing of Global Infusium Brand Acquisition From Procter & Gamble 4Health News:Surprising Allergy Triggers May Be Making Your Spring Sniffles Worse 2Health News:InVitria Announces Launch of Recombinant Albumin for Diagnostics 2
Williams Eye Speculum - 14 mm
Castroviejo Speculum - 15 mm
Snare Wire
Thorton Fixation Ring 13 mm
Medicine Products: